These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7422894

  • 1. Induction of labour with sulprostone after foetal death and in hydatidiform mole.
    Saarikoski S, Selander K, Pystynen P.
    Prostaglandins; 1980 Sep; 20(3):481-5. PubMed ID: 7422894
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience with sulprostone (author's transl)].
    Brabec W, Dapunt O, Bichler A.
    Wien Klin Wochenschr; 1981 Mar 20; 93(6):193-7. PubMed ID: 7281695
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prostaglandin analogue (ONO-802) in treatment of missed abortion, intrauterine fetal death and hydatiform mole: a dose-finding trial.
    Garcea N, Dargenio R, Panetta V, Moneta E, Tancredi G, Giannitelli A.
    Eur J Obstet Gynecol Reprod Biol; 1987 May 20; 25(1):15-22. PubMed ID: 3595971
    [Abstract] [Full Text] [Related]

  • 6. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole.
    Karim SM.
    Br Med J; 1970 Jul 25; 3(5716):196-7. PubMed ID: 5448780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Missed abortion, hydatidiform mole and intra-uterine fetal death treated with 15-methyl-prostaglandin F 2-alpha.
    Boes EG.
    S Afr Med J; 1980 Nov 29; 58(22):878-80. PubMed ID: 7434122
    [Abstract] [Full Text] [Related]

  • 12. Extra amniotic prostaglandins in the management of intrauterine fetal death, anencephaly and hydatidiform mole.
    Embrey MP, Calder AA, Hillier K.
    J Obstet Gynaecol Br Commonw; 1974 Jan 29; 81(1):47-51. PubMed ID: 4818316
    [No Abstract] [Full Text] [Related]

  • 13. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C, Colau JC.
    Rev Fr Gynecol Obstet; 1991 Jan 29; 86(1):53-5. PubMed ID: 2068488
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. III. Its use in some aspects of obstetric pathology].
    Stoppelli I, Piras G, Dessole S.
    Minerva Ginecol; 1983 Dec 29; 35(12):829-31. PubMed ID: 6672684
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simultaneous intravenous infusion of prostaglandin E2 (PGE2) and oxytocin in the management of intrauterine death of the fetus, missed abortion and hydatidiform mole.
    Naismith WC, Barr W.
    J Obstet Gynaecol Br Commonw; 1974 Feb 29; 81(2):146-9. PubMed ID: 4816026
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.